Certification opens the European market for the first FDA-cleared AI platform for prostate MRI interpretation. OMAHA, Neb., Oct. 27, 2025 /PRNewswire/ -- Bot Image, Inc., a leader in AI-powered ...
EDINBURGH, Scotland, Jan. 16, 2024 (GLOBE NEWSWIRE) -- Blackford, the pioneering AI platform and solutions provider, and Bot Image today announced a commercial partnership to bring Bot Image’s ...
CAMBRIDGE, Mass., May 26, 2023 /PRNewswire/ -- The Eureka Clinical AI platform, from ConcertAI's TeraRecon, the advanced visualization and clinical AI SaaS category leader, now provides clinicians ...
A small, Nebraska-based company has received FDA clearance for artificial intelligence-driven software that helps pick out the signs of prostate cancer in MRI scans. Bot Image’s ProstatID program was ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback